Startpage News



INTEGROMED project kick-off meeting in Latvia

Latvian Biomedicine Research and Study centre welcomes project partners from internationally recognized scientific institutions in translational medicine and Diabetes Mellitus research. In the open session of the meeting everyone is welcome to hear presentations from leading professors of INTEGROMED consortium.

Prof. Charlotte Ling (Lund University, SE) is leading Diebetes Epigentics group, her group has made important discoveries such as identification of genome-wide epigenetic modifications in different tissues from type 2 dieabetes patiemts compared with non-diabetic control subjects. Their research also shows that non-genetic factors such as SNPs, exercise, diet, obesity and age alter the genome-wide epigenetic pattern.

Prof. Ewan Pearson (University of Dundee, UK) and his resarch groups research focuss is on the phenotypic and genotypic determinants of drug response in diabetes, and in stratified approaches to the management of diabetes, he also leads international MetGen consortium.

Prof. Eran Segal (Weizmann Institute of Science, IL) is a computational biologist. His lab works on developing quantitative models for all levels of gene regulation, including transcription, chromatin, and translation. He is internationally known for developing algorythms that helps personalize Diabetes treatment and nutrition.

Time: November 29th, 11:00 – 13:30


Place: Latvian Biomedicine Research and Study centre, Rātsupītes iela 1 k-1, Riga




This project has received funding from the European Union's Horizon 2020 research and innovation program under grant agreement No 857572.

Quick links

Mājas lapas izstrādi finansēja ERAF aktivitātes projekts Nr. 2010/0196/2DP/ "Latvijas biomedicīnas pētījumu integrācija Eiropas zinātnes telpā".